» Articles » PMID: 33386786

Killer Cell Immunoglobulin-like Receptors in Thai Patients with Multiple Myeloma

Overview
Date 2021 Jan 2
PMID 33386786
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Natural killer (NK) cells have been implicated in the immune response against multiple myeloma (MM) cells. Killer cell immunoglobulin-like receptors (KIRs) regulate NK cell activity by recognizing specific human leukocyte antigen (HLA) class I as ligands.

Objective: To investigate the association of KIR genes and ligands with MM in the Thai population.

Methods: KIR gene polymorphisms and their HLA ligands were investigated in 66 Thai patients with MM and 200 healthy controls.

Results: The frequencies of KIR3DL1 and 2DS4 were significantly lower in myeloma patients than in controls (P = 0.02). The frequencies of KIR3DL1, 2DS4, 2DL1 with C2, and 3DL1 with Bw4 were significantly higher in the patients achieving > very good partial response (VGPR) than those achieving ≤ VGPR after treatment with bortezomib (P = 0.009, 0.009, 0.01, and 0.02, respectively).

Conclusions: This study suggests the association of KIR genes with the protection against MM and the association of inhibitory KIR and ligands with the response to treatment in MM.

Citing Articles

Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy.

Kamali A, Hamedifar H, Eisenhut M, Bautista J Ther Adv Vaccines Immunother. 2024; 12:25151355241288453.

PMID: 39399301 PMC: 11467827. DOI: 10.1177/25151355241288453.


HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.

Beelen N, Molenbroeck S, Groeneveld L, Voorter C, Bos G, Wieten L Immunogenetics. 2024; 76(3):155-164.

PMID: 38478091 PMC: 11087314. DOI: 10.1007/s00251-024-01336-w.